Medicine
Volume 36, Issue 6 , Pages 300-305 , June 2008

Clinical tuberculosis

References 

  1. Dye C. Global epidemiology of tuberculosis. Lancet. 2006;367:938–940
  2. Rose AMC, Watson JM, Graham C, et al. Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax. 2001;56:173–179
  3. Maguire H, Dale JW, McHugh TD, et al. Molecular epidemiology of tuberculosis in London 1995–7 showing low rate of active transmission. Thorax. 2002;57:617–622
  4. Story A, Murad S, Verheyen M, Roberts W, Hayward AC. Tuberculosis in London – the importance of homelessness, problem drug use and prison. Thorax. 2007;62:667–671
  5. Geng E, Kreiswirth B, Driver C, et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med. 2002;346:1453–1458
  6. Djuretic T, Herbert J, Drobniewski F, et al. Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999. Thorax. 2002;57:477–482
  7. Ruddy MC, Davies AP, Yates MD, et al. Outbreak of isoniazid resistant tuberculosis in north London. Thorax. 2004;59:279–285
  8. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575–1580
  9. Aziz MA, Wright A, Laszlo A, et al. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet. 2006;368:2142–2154
  10. Horsburgh CR. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350:2060–2067
  11. International Union Against Tuberculosis and Lung Disease . Sputum examination for tuberculosis by direct microscopy in low income countries. Paris <http://www.tbrieder.org/publications/microscopy.pdf>2000;
  12. Khan MS, Dar O, Sismanidis C, Shah K, Godfrey-Faussett P. Improvement of tuberculosis case detection and reduction of discrepancies between men and women by simple sputum-submission instructions: a pragmatic randomised controlled trial. Lancet. 2007;369:1955–1960
  13. van Cleeff MR, Kivihya-Ndugga L, Githui W, Nganga L, Odhiambo J, Klatser PR. A comprehensive study of the efficiency of the routine pulmonary tuberculosis diagnostic process in Nairobi. Int J Tuberc Lung Dis. 2003;7:186–189
  14. Aluoch JA, Swai OB, Edwards EA, et al. Studies of case-finding for pulmonary tuberculosis in outpatients at 4 district hospitals in Kenya. Tubercle. 1985;66:237–249
  15. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55:32–38
  16. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 1999;3(suppl 2):S231–S279
  17. World Health Organization – Stop TB Partnership . The stop TB strategy. <http://www.who.int/tb/publications/2006/who_htm_tb_2006_368.pdf>2006;
  18. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003343
  19. Newell JN, Baral SC, Pande SB, Bam DS, Malla P. Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet. 2006;367:903–909
  20. World Health Organization – Stop TB Partnership . Guidelines for the programmatic management of drug-resistant tuberculosis. <http://www.stoptb.org/resource_center/assets/documents/tb_guidelines.pdf>2006;
  21. Mitchison DA, Nunn AJ. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis. 1986;133:423–430
  22. Thwaites GE, Chau TT, Stepniewska K, et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet. 2002;360:1287–1292
  23. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351:1741–1751
  24. Perriens JH, St Louis ME, Mukadi YB, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med. 1995;332:779–784
  25. Wiktor SZ, Sassan-Morokro M, Grant AD, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d’Ivoire: a randomised controlled trial. Lancet. 1999;353:1469–1475
  26. Shelburne SA, Hamill RJ. The immune reconstitution inflammatory syndrome. AIDS Rev. 2003;5:67–79
  27. World Health Organization . WHO Report 2007. Global tuberculosis control surveillance, planning, financing. <http://www.who.int/tb/publications/global_report/2007/pdf/full.pdf>2007;
  28. Godfrey-Faussett P, Sonnenberg P, et al. Tuberculosis control and molecular epidemiology in a South African gold-mining community. Lancet. 2000;356:1066–1071

PII: S1357-3039(08)00101-1

doi: 10.1016/j.mpmed.2008.03.008

Medicine
Volume 36, Issue 6 , Pages 300-305 , June 2008

Article Tools

* Image Usage & Resolution